Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2010. Start Trial.
Date Value
September 30, 2026 0.032M
June 30, 2026 -0.261M
March 31, 2026 4.043M
December 31, 2025 1.403M
September 30, 2025 16.99M
June 30, 2025 4.351M
March 31, 2025 -0.005M
December 31, 2024 0.00
September 30, 2024 0.03M
June 30, 2024 0.00
March 31, 2024 12.01M
December 31, 2023 -0.068M
September 30, 2023 8.939M
June 30, 2023 -3.333M
March 31, 2023 -2.072M
December 31, 2022 5.296M
September 30, 2022 -1.637M
June 30, 2022 -2.083M
March 31, 2022 -2.083M
December 31, 2021 11.84M
September 30, 2021 -2.461M
June 30, 2021 -2.082M
March 31, 2021 34.22M
December 31, 2020 7.853M
September 30, 2020 7.522M
Date Value
June 30, 2020 0.665M
March 31, 2020 0.916M
December 31, 2019 0.001M
September 30, 2019 1.55M
June 30, 2019 14.70M
March 31, 2019 -1.794M
December 31, 2018 51.36M
September 30, 2018 19.88M
June 30, 2018 5.508M
March 31, 2018 -1.722M
December 31, 2017 -0.883M
September 30, 2017 13.11M
June 30, 2017 0.011M
March 31, 2017 0.093M
December 31, 2016 0.00
September 30, 2016 -0.147M
June 30, 2016 0.00
March 31, 2016 0.121M
December 31, 2015 2.506M
September 30, 2015 58.91M
June 30, 2015 -2.15M
March 31, 2015 0.369M
December 31, 2014 -0.517M
September 30, 2014 1.657M
June 30, 2014 10.17M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Relmada Therapeutics, Inc. 0.0177M
Journey Medical Corp. 0.117M
ANI Pharmaceuticals, Inc. -9.829M
Corcept Therapeutics, Inc. -23.88M
Veru, Inc. -0.0519M